DUTCH Test: What Your Results Change About Your Treatment

What the DUTCH Test Actually Measures

The DUTCH test captures a 24-hour snapshot of hormone production and metabolism using dried urine collected on filter paper at four or five time points. It reports not just parent hormones (estradiol, progesterone, testosterone, cortisol) but their downstream metabolites. This is the distinction that matters clinically.

Parent Hormones vs. Metabolites

Serum blood draws tell you how much estradiol or testosterone is circulating at a single moment. The DUTCH test adds a second layer: it shows what your liver and gut do with those hormones after they enter circulation. Estrogen, for example, is metabolized through three primary phase I pathways (2-hydroxylation, 4-hydroxylation, and 16-hydroxylation), each carrying different clinical implications. The 4-OH pathway produces catechol estrogens associated with oxidative DNA damage, while the 2-OH pathway is generally considered more favorable [1]. A 2018 review in the Journal of Clinical Endocrinology & Metabolism confirmed that urinary estrogen metabolite ratios correlate with breast tissue proliferation markers more reliably than total serum estradiol alone [2].

The Cortisol Curve

Standard serum cortisol is a single-point measurement, typically drawn in the morning. The DUTCH test plots free cortisol across four time points (waking, morning, afternoon, evening) and also quantifies total cortisol metabolites (tetrahydrocortisol, tetrahydrocortisone, and their 5-alpha variants). This separation matters because a patient can have normal free cortisol levels but very low total cortisol metabolites, indicating that the adrenal glands produce adequate cortisol but the body clears it too rapidly [3]. The Endocrine Society's 2016 guidelines on adrenal insufficiency emphasize that 24-hour urinary free cortisol collection provides diagnostic value that single-point serum measurements miss [4].

How DUTCH Results Alter Estrogen Therapy

Your DUTCH metabolite profile can directly change which form of estrogen your clinician prescribes, at what dose, and whether protective supplements are added. This is where the test earns its clinical value.

The 2-OH, 4-OH, and 16-OH Decision Tree

When DUTCH results show a patient's estrogen metabolism is weighted toward the 4-OH pathway (4-hydroxyestrone elevated above the lab's reference range, typically above 3.0 ng/mg creatinine), clinicians often respond by adding DIM (diindolylmethane) at 100 to 200 mg daily or calcium-d-glucarate at 1,500 mg daily to shift metabolism toward the 2-OH pathway. A 2017 study in Nutrition and Cancer (N=47) found that DIM supplementation at 108 mg/day shifted the urinary 2:16 hydroxyestrone ratio by 47% in postmenopausal women over 30 days [5].

Conversely, if the 2-OH pathway is dominant but methylation is impaired (indicated by elevated 2-OH-E1 with low 2-methoxy-E1), the clinical response shifts to supporting COMT methylation with methylated B vitamins, magnesium, and SAMe rather than adding DIM.

Route of Delivery Decisions

Oral estradiol undergoes first-pass hepatic metabolism, which increases estrone (E1) and its downstream metabolites. When a patient's DUTCH test already shows elevated E1 relative to E2, or elevated 4-OH metabolites, the clinical logic favors transdermal estradiol to bypass that hepatic first pass. The 2022 NICE menopause guidelines and the North American Menopause Society (NAMS) 2022 position statement both note that transdermal estradiol avoids the prothrombotic hepatic effects of oral administration [6]. DUTCH data gives a metabolite-level reason to make that switch rather than relying on risk-factor checklists alone.

Dose Titration With Metabolite Feedback

A woman on 0.1 mg/day transdermal estradiol may have a serum estradiol of 60 pg/mL, which looks adequate. But if her DUTCH test shows total estrogen metabolites are below the 25th percentile for her age group, her tissue-level estrogen exposure may be lower than the serum number suggests. Her clinician might increase the patch dose to 0.125 mg/day and retest in 90 days. Serum and urine data together produce a more complete dosing picture than either one alone.

How DUTCH Results Change Progesterone Protocols

Serum progesterone confirms whether ovulation occurred or whether supplementation is reaching circulation. DUTCH testing adds the metabolite layer: it measures pregnanediol, the primary urinary metabolite of progesterone.

Oral vs. Topical Progesterone Detection

One practical reality: topical (transdermal) progesterone often fails to raise serum progesterone levels meaningfully, which has led some clinicians to conclude it "doesn't work." But DUTCH testing frequently detects elevated pregnanediol in women using topical progesterone whose serum levels remain flat. A 2019 publication in Menopause found that salivary and urinary progesterone metabolites identified tissue exposure from topical progesterone that serum testing missed [7]. This distinction matters because it prevents unnecessary dose escalation or an unwarranted switch to oral micronized progesterone when the topical route is already achieving tissue-level effect.

Adjusting for 5-Alpha Reductase Activity

Some women metabolize progesterone heavily through the 5-alpha reductase pathway, producing elevated allopregnanolone. This metabolite has strong GABAergic (sedative) activity. When DUTCH shows a high ratio of 5-alpha pregnanediol to total pregnanediol, and the patient reports excessive drowsiness or mood disruption on progesterone, the prescriber may reduce the dose, shift timing to bedtime only, or switch from oral (which amplifies first-pass 5-alpha reduction) to vaginal administration.

What DUTCH Cortisol Patterns Mean for Treatment

The cortisol section of a DUTCH test frequently changes clinical decisions around adrenal support, adaptogens, and even thyroid medication timing.

High Free Cortisol, Normal Metabolites

This pattern suggests the HPA axis is running hot but clearance is normal. Treatment often focuses on calming the axis: phosphatidylserine (400 to 800 mg at bedtime), ashwagandha (300 to 600 mg standardized KSM-66), and sleep hygiene optimization. The Endocrine Society recommends against diagnosing Cushing syndrome from urinary free cortisol unless values exceed three to four times the upper limit of normal on at least two 24-hour collections [4].

Low Free Cortisol, Low Metabolites

This combination points toward genuine adrenal insufficiency or low total cortisol output. The clinical next step is typically a morning serum cortisol and possibly an ACTH stimulation test. The 2016 Endocrine Society clinical practice guideline on adrenal insufficiency states that a morning serum cortisol below 3 mcg/dL strongly suggests adrenal insufficiency, while values above 15 mcg/dL effectively rule it out [4]. DUTCH cannot diagnose Addison disease, but it can flag the pattern that triggers the confirmatory workup.

Normal Free Cortisol, Low Metabolites

This is the pattern serum testing misses entirely. The patient looks biochemically normal on a morning blood draw, but their total daily cortisol production is low. Clinicians may respond with low-dose DHEA (5 to 25 mg), adrenal glandulars, or adaptogenic herbs depending on the patient's symptom burden. A flattened diurnal curve (low morning, relatively higher evening) additionally prompts evaluation for circadian disruption, shift work, or chronic insomnia.

DUTCH and Testosterone / DHEA Management

For men on TRT and women using low-dose testosterone, DUTCH adds the metabolite perspective that serum testing alone cannot provide.

5-Alpha vs. 5-Beta Pathway Balance

Testosterone is metabolized through two primary reductive pathways: 5-alpha reductase (producing androsterone and etiocholanolone's 5-alpha counterpart) and 5-beta reductase. When the DUTCH test shows heavy 5-alpha dominance, clinicians may anticipate more DHT-related side effects (acne, hair thinning, prostate stimulation in men). This can prompt the addition of saw palmetto, topical ketoconazole, or in some cases low-dose finasteride, even before symptoms appear. A 2020 meta-analysis in Prostate Cancer and Prostatic Diseases (N=4,565 across 16 trials) confirmed that 5-alpha reductase inhibitors reduce prostate volume by 18 to 28% over 12 months [8].

DHEA-S and Its Downstream Allocation

DUTCH measures DHEA-S and its metabolites, revealing whether supplemental DHEA is preferentially converting toward androgens or estrogens. In a postmenopausal woman taking 25 mg DHEA who shows high androgenic metabolites and new-onset acne, the test provides the rationale to cut the dose to 10 mg or add 7-keto DHEA, which does not convert to sex steroids. Without this metabolite data, the dose adjustment is guesswork.

When Serum Labs Are Still Necessary

DUTCH testing does not replace serum blood work. It complements it. Several clinical scenarios still require serum measurement as the primary tool.

Scenarios Requiring Serum Labs

Thyroid function (TSH, free T4, free T3) is not captured by DUTCH. Neither is fasting insulin, hemoglobin A1c, lipid panels, CBC, or hepatic function. LH and FSH, which are necessary for diagnosing primary vs. Secondary hypogonadism, require serum measurement. The American Association of Clinical Endocrinologists (AACE) 2020 guidelines on male hypogonadism specify that diagnosis requires two morning serum total testosterone measurements below 300 ng/dL [9]. DUTCH testing does not fulfill this diagnostic criterion.

Combining DUTCH With Serum for Optimal Monitoring

The most clinically useful approach pairs a standard serum hormone panel (drawn fasting, 8 to 10 AM) with a DUTCH test run during the same week. Serum confirms circulating levels; DUTCH reveals what happens after those hormones leave the bloodstream. For women on HRT, the Endocrine Society's 2019 guidelines recommend monitoring serum estradiol, and DUTCH metabolite testing layers on the safety and optimization data that serum alone does not capture [10].

How to Read Your DUTCH Results

DUTCH reports are dense. They typically run 8 to 12 pages and include color-coded reference ranges, metabolite ratios, and clinical commentary. Patients should review their results with a clinician trained in functional hormone interpretation rather than self-treating based on the report alone.

Key Numbers to Discuss With Your Provider

Estrogen metabolite ratios (2-OH:16-OH and 4-OH:2-OH), total cortisol metabolites (listed in micrograms per 24 hours), melatonin metabolite (6-OH-melatonin-sulfate, which reflects sleep-cycle health), and the free cortisol pattern are the four sections most likely to trigger a treatment change. Your provider should compare these values against both the lab's reference range and your own prior results to track the direction of change.

Retesting Timelines

After any protocol adjustment (new supplement, changed HRT dose, route switch), allow a minimum of 8 to 12 weeks before retesting. Metabolic pathway shifts require time to stabilize. The DUTCH Complete and DUTCH Plus panels offer slightly different cortisol assessment methods (dried urine vs. Salivary cortisol awakening response), so ensure you retest with the same panel version for accurate comparison.

Normal DUTCH Test Ranges

DUTCH reference ranges are sex- and age-specific. They are also menstrual-cycle-phase-specific for premenopausal women; the luteal-phase collection window (days 19 to 22 of a 28-day cycle) is the standard timing for most clinical decisions.

Typical reference midpoints for premenopausal women in the luteal phase include estradiol metabolites summing to 8 to 15 mcg/24 hr, pregnanediol between 800 and 2,500 ng/mg creatinine, and a free cortisol sum (four time points) of 80 to 180 mcg/24 hr. For postmenopausal women not on HRT, estrogen metabolites drop substantially, and the clinical focus shifts to relative pathway ratios rather than absolute values. Precision Analytics (the company behind DUTCH) publishes updated reference ranges annually, and clinicians should verify against the most recent version on the report header.